Device Transactions Device companies raised a total of $1.2 billion in financing in the fourth quarter, a 16% decrease from Q3's $1.4 billion. Q4 turned out to have the second-lowest financing aggrega
Medtech M&A activity has been on the rise for several years and shows no signs of slowing down. The industry has seen its deals getting bigger and bigger, giving way to a surge in the number of higher
Companies making in-vitro diagnostic technology and cardiovascular products were the most popular targets for mergers and acquisitions in the medical technology space during 2015. That is according to
Device Transactions Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. ( See Exhibit 1. ) Late-stage venture capital rounds represented most of